APA (7th ed.) Citation

MK, P., L, B., M, G., SM, N., F, X., AS, C., . . . J, T. (2020). Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. Journal of surgical oncology, 121(3), 447. https://doi.org/10.1002/jso.25814

Chicago Style (17th ed.) Citation

MK, Pomponio, et al. "Refining the Indications for Neoadjuvant Chemotherapy for Patients with HER2+ Breast Cancer: A Single Institution Experience." Journal of Surgical Oncology 121, no. 3 (2020): 447. https://doi.org/10.1002/jso.25814.

MLA (9th ed.) Citation

MK, Pomponio, et al. "Refining the Indications for Neoadjuvant Chemotherapy for Patients with HER2+ Breast Cancer: A Single Institution Experience." Journal of Surgical Oncology, vol. 121, no. 3, 2020, p. 447, https://doi.org/10.1002/jso.25814.